The National Institutes of Health (NIH) requires that institutions establish an Institutional Biosafety Committee (IBC) to ensure that all recombinant DNA research be conducted in compliance with the NIH Guidelines for Research Involving Recombinant DNA Molecules. The IBC also reviews research protocols involving potential biohazards such as human, animal or plant pathogens; human materials (blood, cells, cell lines, tissues, body fluids, organs); and select agents (restricted human and animal pathogens and toxins that are considered by CDC to pose a potential threat to public health and safety).
Our Services
Processes, reviews and approves research protocols involving rDNA and other biohazards to ensure compliance with institutional, state and federal regulations
Assesses the facilities, procedures, practices, and training and expertise of personnel involved in research involving biohazards
Assists researchers to ensure that proper biosafety containment practices are used
Maintains institutional records of approved protocols and required reports to the NIH Office of Biosafety Activities
Contact Information:
Vanessa Rodriguez, CIP
Senior IRB/IBC Coordinator
Phone: 516-514-2445
IBC Office IBCOffice@NJHEALTH.ORG
